Connection

Konstantinos Syrigos to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Carcinoma, Non-Small-Cell Lung.
Konstantinos Syrigos
Connection Strength
2.127
Carcinoma, Non-Small-Cell Lung
  1. Epidemiological Characteristics, EGFR Status and Management Patterns of Advanced Non-small Cell Lung Cancer Patients: The Greek REASON Observational Registry Study. Anticancer Res. 2018 Jun; 38(6):3735-3744.
    View in: PubMed
    Score: 0.377
  2. Khorana Score: ?ew Predictor of Early Mortality in Patients With Lung Adenocarcinoma. Clin Appl Thromb Hemost. 2018 Nov; 24(8):1347-1351.
    View in: PubMed
    Score: 0.376
  3. Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis. In Vivo. 2017 Jul-Aug; 31(4):641-648.
    View in: PubMed
    Score: 0.353
  4. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2019 11 21; 381(21):2020-2031.
    View in: PubMed
    Score: 0.103
  5. A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer. Lung Cancer. 2019 10; 136:52-56.
    View in: PubMed
    Score: 0.102
  6. Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer. Curr Med Res Opin. 2019 10; 35(10):1761-1767.
    View in: PubMed
    Score: 0.102
  7. Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis. Clin Cancer Res. 2019 08 01; 25(15):4663-4673.
    View in: PubMed
    Score: 0.100
  8. Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations. J Thorac Oncol. 2018 12; 13(12):1884-1896.
    View in: PubMed
    Score: 0.096
  9. Circulating tumor cells count as a predictor of survival in lung cancer. Crit Rev Oncol Hematol. 2018 May; 125:60-68.
    View in: PubMed
    Score: 0.093
  10. Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer. Clin Cancer Res. 2018 04 01; 24(7):1562-1573.
    View in: PubMed
    Score: 0.091
  11. Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG). J Neurooncol. 2017 Sep; 134(2):443-451.
    View in: PubMed
    Score: 0.088
  12. Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer. Lung Cancer. 2017 10; 112:126-133.
    View in: PubMed
    Score: 0.088
  13. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Clin Cancer Res. 2017 Sep 01; 23(17):5202-5209.
    View in: PubMed
    Score: 0.088
  14. Programmed death ligand-1 expression in non-small cell lung cancer. Lab Invest. 2014 Jan; 94(1):107-16.
    View in: PubMed
    Score: 0.069
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.